Sino Biopharmaceutical Limited Stock Today
| SBMFF Stock | USD 0.38 0.01 2.70% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sino Biopharmaceutica is trading at 0.38 as of the 16th of April 2024. This is a 2.70 percent up since the beginning of the trading day. The stock's lowest day price was 0.38. Sino Biopharmaceutica has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sino Biopharmaceutical Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of January 2024 and ending today, the 16th of April 2024. Click here to learn more.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.. The company has 18.81 B outstanding shares. More on Sino Biopharmaceutical Limited
Moving against Sino Pink Sheet
| 0.55 | BIMT | Bitmis Corp | PairCorr |
| 0.48 | YUMM | Yummies | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sino Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sino Biopharmaceutica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sino Biopharmaceutica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Xiaoyang Xu |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Sino Biopharmaceutical Limited [SBMFF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sino Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sino Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sino Biopharmaceutical classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 18.81 B outstanding shares.
Sino Biopharmaceutical Limited has accumulated about 15.67 B in cash with 5.37 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sino Biopharmaceutica Probability Of Bankruptcy
Ownership AllocationSino Biopharmaceutical shows a total of 18.81 Billion outstanding shares. Sino Biopharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sino Ownership Details
Sino Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Sino Biopharmaceutica jumping above the current price in 90 days from now is about 37.43%. The Sino Biopharmaceutical Limited probability density function shows the probability of Sino Biopharmaceutica pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Sino Biopharmaceutical Limited has a beta of -0.1524. This usually implies as returns on the benchmark increase, returns on holding Sino Biopharmaceutica are expected to decrease at a much lower rate. During a bear market, however, Sino Biopharmaceutical Limited is likely to outperform the market. Additionally, sino Biopharmaceutical Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Sino Biopharmaceutica to move above the current price in 90 days from now is about 37.43 (This Sino Biopharmaceutical Limited probability density function shows the probability of Sino Pink Sheet to fall within a particular range of prices over 90 days) .
Sino Biopharmaceutical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sino Biopharmaceutica market risk premium is the additional return an investor will receive from holding Sino Biopharmaceutica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sino Biopharmaceutica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sino Biopharmaceutica's alpha and beta are two of the key measurements used to evaluate Sino Biopharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
Sino Stock Against Markets
Picking the right benchmark for Sino Biopharmaceutica pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sino Biopharmaceutica pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sino Biopharmaceutica is critical whether you are bullish or bearish towards Sino Biopharmaceutical Limited at a given time. Please also check how Sino Biopharmaceutica's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sino Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Sino Biopharmaceutica Corporate Directors
Sino Biopharmaceutica corporate directors refer to members of a Sino Biopharmaceutica board of directors. The board of directors generally takes responsibility for the Sino Biopharmaceutica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Sino Biopharmaceutica's board members must vote for the resolution. The Sino Biopharmaceutica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Cheung Cheng | Executive Director and Member of Executive Board Committee | Profile | |
| Hsin Tse | VP, General Manager of Audit Department, Executive Director and Member of Executive Board Committee | Profile | |
| Zhengfei Lu | Independent Non-Executive Director | Profile | |
| Wenyu Xia | General Manager and Director of Jiangsu Fenghai | Profile |
How to buy Sino Pink Sheet?
Before investing in Sino Biopharmaceutica, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sino Biopharmaceutica. To buy Sino Biopharmaceutica stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sino Biopharmaceutica. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Sino Biopharmaceutica stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Sino Biopharmaceutical Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Sino Biopharmaceutical Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sino Biopharmaceutical Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Sino Biopharmaceutical Limited?
The danger of trading Sino Biopharmaceutical Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sino Biopharmaceutica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sino Biopharmaceutica. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sino Biopharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sino Biopharmaceutical Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Sino Biopharmaceutical information on this page should be used as a complementary analysis to other Sino Biopharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Sino Pink Sheet analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |